Hinge Health, Inc. (HNGE) experienced a significant pre-market surge of 9.15% on Wednesday, following the release of its first-quarter 2026 financial results which significantly exceeded analyst expectations.

The digital health company reported revenue of $182.3 million, a 47% year-over-year increase that beat the consensus estimate of $172.2 million. Adjusted earnings per share came in at $0.45, surpassing the expected $0.38-$0.40 range. Management also raised its full-year 2026 revenue outlook to $798 million-$804 million, up substantially from prior guidance of $732 million-$742 million.

The strong results prompted multiple analyst upgrades, with Canaccord Genuity raising its price target to $63 from $53 and RBC increasing its target to $65 from $55. The company's expansion into new care categories and profitable growth trajectory were highlighted as key drivers for the positive market reaction.